Search over 3,000 reports

    Gilvec - API Insights, 2017

    Gilvec - API Insights, 2017
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 30
    Geography: Global
    Delivery Timeline: 48 Hours
    SKU: DIDA0057
    DelveInsight's, Gilvec - API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Gilvec. The report also highlights the patent details of Gilvec.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
    Evaluate the marketing status of Gilvec to exploit opportunities for generic Gilvec development opportunities
    Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Gilvec
    API intelligence over Gilvec and gaining primary intelligence over Active Ingredient manufacturers by country
    Make more informed business decisions from insightful and in-depth analysis of the Gilvec's performance
    Gilvec Overview
    Gilvec Global Sales Assessment
    Gilvec Historical Global Sales
    Gilvec Forecasted Global Sales
    Product Description
    Mechanism of Action
    Pharmacodynamic Properties
    Pharmacokinetic Properties
    Product Details by country
    Patent Information
    Global API Manufacturers Assessment
    Active Pharmaceutical Ingredient (API) Manufacturers by Country
    Active Pharmaceutical Ingredient (API) Manufacturers by Region
    Consulting Services
    About DelveInsight
    Table 1: Gilvec Historical Global Sales from 2009-2016 (in million USD)
    Table 2: Gilvec Forecasted Global Sales from 2017-2022 (in million USD)
    Table 3: Gilvec General Description
    Table 4: Product Details by country
    Table 5: Patent Information
    Table6: API Manufacturers by country
    Table 7: API Manufacturers by Region
    Figure 1: Gilvec Historical Global Sales from 2009-2016 (in million USD)
    Figure 2: Gilvec Forecasted Global Sales from 2017-2022 (in million USD)
    Figure 3: Gilvec Patent Details
    Figure 4: Gilvec API Manufacturers by Country
    Figure 5: Gilvec API Manufacturers by Region
    Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML), myelodysplastic/ myeloproliferative diseases; aggressive systemic mastocytosis; hypereosinophilic syndrome; chronic eosinophilic leukemia (CEL); gastrointestinal stromal tumors
    (GIST); dermatofibrosarcoma protuberans (DFSP)
    Gilvec Marketed Drugs Overview
    Gilvec Market Assessment
    Gilvec API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Gilvec US DMF
    Gilvec US Drug Master Files
    Gilvec Active Substance Master File/ EUDMF
    Gilvec Generic players
    Gilvec Patent Expiration
    Gilvec Patent Exclusivity
    Gilvec API Manufacturers
    Gilvec Global Forecasted Sales Figure
    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap